Rôle et impact du pharmacien en oncologie : revue de la littérature.

Although pharmacists have been involved in oncology for decades, there is no recent literature review highlighting the pharmacist roles and impacts in this area. The objective of this article is to present a literature review of the roles and benefits of oncology pharmacist. Method: Literature review. A search strategy on PubMed was conducted from January 1990 to July 7, 2016. The search strategy used the following keywords: pharmacist, pharmacy, clinical pharmacy, pharmaceutical services, pharmaceutical care, neoplasms. The studies addressing the roles and benefits of oncology pharmacist were considered. Results: 22 articles were included (e.g. 15 observational/descriptive studies, 2 cohort studies, 2 randomized controlled trials, 2 before and after studies, 1 comparative study). Regarding the descriptive indicators and impact of pharmaceutical interventions in oncology, our literature review revealed 77% (72/94) descriptive indicators and 23% (22/94) outcome indicators. Of the 22 outcome indicators identified, they were either positive (82%, 18/22) or neutral (18%, 4/22) and they were related to following impacts: morbidity (9%, 2/22), adverse events (4.5%, 1/22), medication errors (14%, 3/22), patient adherence (9%, 2/22), satisfaction (4.5%, 1/22), costs (9%, 2/22) and other benefits (50%, 11/22). Conclusion: Relatively little data on the roles and benefits of pharmacists has been published. Many scientific societies consider the pharmacist as an important member in the multidisciplinary team whose goal is to provide care to cancer patients. [ABSTRACT FROM AUTHOR]